ARKZ yields 100.41% · PFE yields 6.13%● Live data
📍 ARKZ pulled ahead of the other in Year 1
Combined, ARKZ + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ARKZ + PFE for your $10,000?
ARKZ holds standardized, cash-settled Ether futures traded on the Chicago Mercantile Exchange (CME). With a targeted allocation of over 25% of total assets, the fund operates through a subsidiary structure based in the Cayman Islands. The fund employs a rolling strategy that seeks optimal roll yield by investing in contracts with the most attractive combination of cost, liquidity, and other relevant factors. Typically, these contracts have monthly or quarterly contract periods. Moreover, the fund may invest in front-month Ether Futures contracts and usually rolls to the next nearby contracts at the time believed to generate the greatest roll yield. To provide liquidity and collateral for Ether Futures investments, the remaining assets are diversified into short-term cash instruments, including U.S. Treasury securities and money market instruments. Additionally, the fund may engage in leveraging through reverse repurchase agreements.
Full ARKZ Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.